BIOMAT Database Logo BIOMAT Database Logo

[Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)]. 1974

K Iwai, and H Honda, and S Yamada, and M Fukase

UI MeSH Term Description Entries
D008297 Male Males
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004987 Ethers Organic compounds having two alkyl or aryl groups bonded to an oxygen atom, as in the formula R1–O–R2.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000731 Androstanes The family of steroids from which the androgens are derived.
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias
D013440 Sulfides Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. Sulfide,Thioether,Thioethers,Sulfur Ethers,Ethers, Sulfur
D045930 Anabolic Agents These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. Anabolic Effect,Anabolic Effects,Agents, Anabolic,Effect, Anabolic,Effects, Anabolic

Related Publications

K Iwai, and H Honda, and S Yamada, and M Fukase
[Proceedings: Anti-estrogen action of 2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1-methoxy-cyclopentyl ether (10364-S)].
February 1974, Nihon Naibunpi Gakkai zasshi,
K Iwai, and H Honda, and S Yamada, and M Fukase
Proceedings: 2 alpha, 3 alpha-epithio-5alpha-androstan-17beta-YL 1-methoxy-cyclophenyl ether (10364-S), a new orally active anabolic-androgenic steroid.
January 1974, Japanese journal of pharmacology,
K Iwai, and H Honda, and S Yamada, and M Fukase
[Proceedings: Clinical experience with administration of 2 alpha, 3 alpha- epithio-5 alpha-androstan-17 beta- yl, 1-methoxy-cyclopentyl ether (10364-S) in breast diseases].
February 1974, Nihon Naibunpi Gakkai zasshi,
K Iwai, and H Honda, and S Yamada, and M Fukase
2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
June 1974, Steroids,
K Iwai, and H Honda, and S Yamada, and M Fukase
2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether (10361-S), a new orally active anabolic-androgenic steroid.
August 1974, Japanese journal of pharmacology,
K Iwai, and H Honda, and S Yamada, and M Fukase
2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-OL in the treatment of chronic mastopathy.
September 1968, Endocrinologia japonica,
K Iwai, and H Honda, and S Yamada, and M Fukase
Syntheses of 1-alpha,2-alpha- and 1-beta,2-beta-epithio-A-nor-5-alpha-androstan-17-beta-ol and related compounds.
December 1967, Chemical & pharmaceutical bulletin,
K Iwai, and H Honda, and S Yamada, and M Fukase
Effect of 5 alpha-androstan-17 beta-ol-3-one (DHT) and 5 alpha-androstan-3 alpha, 17 beta-diol (3 alpha-diol) on ether-induced prolactin secretion.
July 1982, Experientia,
K Iwai, and H Honda, and S Yamada, and M Fukase
[Steroids 28. Preparation of steroid hormone analogs from 2,3 beta-imino-5 alpha-androstan-17 beta-ol and 2 beta-amino-3 alpha-chlor-5 alpha-androstan-17 beta-ol].
January 1971, Chemische Berichte,
K Iwai, and H Honda, and S Yamada, and M Fukase
Metabolism of 5 alpha-androstane-3 beta,17 beta-diol to 17 beta-hydroxy-5 alpha-androstan-3-one and 5 alpha-androstan-3 alpha,17 beta-diol in the rat.
August 1979, Biochimica et biophysica acta,
Copied contents to your clipboard!